COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,877 Articles (22,568 medRxiv, 8,309 bioRxiv)

Most recent first Previous |  Page 1425: Articles 14241-14250  | Next

DNA damage response at telomeres boosts the transcription of SARS-CoV-2 receptor ACE2 during aging
Sepe, S., Rossiello, F., Cancila, V., Iannelli, F., Matti, V., Cicio, G., Cabrini, M., Marinelli, E., Alabi, B., di Lillo, A., Di Napoli, A., Shay, J. W., Tripodo, C., d'Adda di Fagagna, F.
10.1101/2021.06.09.447484 — Posted: 2021-06-09 Discussion: Onsite | Offsite
Monitoring group activity of hamsters and mice as a novel tool to evaluate COVID-19 progression, convalescence and rVSV-ΔG-spike vaccination efficacy
Melamed, S., Politi, B., Grauer, E., Achdout, H., Aftalion, M., Gur, D., Tamir, H., Yahalom-Ronen, Y., Maimon, S., Yitzhak, E., Weiss, S., Rosner, A., Erez, N., Yitzhaki, S., Shapira, S. C., Paran, N., Mamroud, E., Vagima, Y., Israely, T.
10.1101/2021.06.09.447687 — Posted: 2021-06-09
The fatty acid site is coupled to functional motifs in the SARS-CoV-2 spike protein and modulates spike allosteric behaviour
Oliveira, A. S., Shoemark, D., Ibarra, A. A., Davidson, A. D., Berger, I., Schaffitzel, C., Mulholland, A. J.
10.1101/2021.06.07.447341 — Posted: 2021-06-09
Cellular Activities of SARS-CoV-2 Main Protease Inhibitors Reveal Their Unique Characteristics
Cao, W., Cho, C.-C. D., Geng, Z. Z., Ma, X. R., Allen, R., Shaabani, N., Vatansever, E. C., Alugubelli, Y. R., Ma, Y., Ellenburg, W. H., Yang, K. S., Qiao, Y., Ji, H., Xu, S., Liu, W. R.
10.1101/2021.06.08.447613 — Posted: 2021-06-09
Multi-color super-resolution imaging to study human coronavirus RNA during cellular infection
Wang, J., Han, M., Wang, H., Moeckl, L., Zeng, L., Moerner, W. E., Qi, L. S.
10.1101/2021.06.09.447760 — Posted: 2021-06-09
Intranasal administration of a monoclonal neutralizing antibody protects mice against SARS-CoV-2 infection
Halwe, S., Kupke, A., Vanshylla, K., Liberta, F., Gruell, H., Zehner, M., Rohde, C., Kraehling, V., Gellhorn-Serra, M., Kreer, C., Kluever, M., Sauerhering, L., Schmidt, J., Cai, Z., Han, F., Young, D., Yang, G., Widera, M., Koch, M., Werner, A., Kaemper, L., Becker, N., Marlow, M. S., Eickmann, M., Ciesek, S., Schiele, F., Klein, F., Becker, S.
10.1101/2021.06.09.447662 — Posted: 2021-06-09
Immunogenicity and In vivo protection of a variant nanoparticle vaccine that confers broad protection against emerging SARS-CoV-2 variants
Logue, J., Johnson, R., Patel, N., Zhou, B., Maciejewski, S., Zhou, H., Portnoff, A., Tian, J.-H., McGrath, M., Haupt, R., Weston, S., Hammod, H., Guebre-Xabier, M., Dillen, C., Plested, J., Cloney-Clark, S., Greene, A., Massare, M., Glenn, G., Smith, G., Frieman, M.
10.1101/2021.06.08.447631 — Posted: 2021-06-09
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 B.1.351 and other variants of concern in preclinical studies.
Spencer, A. J., Morris, S., Ulaszewska, M., Powers, C., Kaliath, R., Bissett, C. D., Truby, A., Thakur, N., Newman, J., Allen, E. R., Lui, C., Dejnirattisai, W., Mongkolsapaya, J., Davies, H., Donnellan, F. R., Pulido, D., Peacock, T. P., Barclay, W. S., Bright, H., Ren, K., Screaton, G., McTammy, P., Bailey, D., Gilbert, S. C., Lambe, T.
10.1101/2021.06.08.447308 — Posted: 2021-06-09
Percolation across households in mechanistic models of non-pharmaceutical interventions in SARS-CoV-2 disease dynamics
Franco, C., Ferreira, L. S., Sudbrack, V., Borges, M. E., Poloni, S., Prado, P. I., White, L. J., Aguas, R., Kraenkel, R. A., Coutinho, R. M.
10.1101/2021.06.07.21258403 — Posted: 2021-06-09
Operationalizing a routine wastewater monitoring laboratory for SARS-CoV-2
Kantor, R. S., Greenwald, H. D., Kennedy, L. C., Hinkle, A., Harris-Lovett, S., Metzger, M., Thornton, M., Paluba, J., Nelson, K. L.
10.1101/2021.06.06.21258431 — Posted: 2021-06-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).